CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced the formation of Relay Therapeutics with $57 million in Series A financing, including participation from an affiliate of D.

A picture may be worth a thousand words, but when it comes to disease discovery, Bay Area VC firm Third Rock Ventures is betting its money on moving pictures. But instead of Hollywood blockbusters, ...

Relay Therapeutics, which aims to take down difficult cancer drug targets by combining powerful computational methods with emerging lab tools, has raised a whopping $400 million in its third formal ...

Billed as a first-of-its kind safety relay, the Allen-Bradley Guardmaster Minotaur MSR57P dedicated safe-speed monitoring relay is designed to allow personnel to enter hazardous areas while motion is ...

Relay Therapeutics, which aims to take down difficult cancer drug targets by combining computational methods with emerging lab tools, has raised a whopping $400 million in its third formal financing ...

A discovery-stage biopharma startup focused on protein motion in drug discovery has raised a round of financing more than six times as big as the last one. Relay Therapeutics, based in Cambridge, ...